Title: Final guidance, “Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products.”
Men who have sex with men will be deferred from donating blood for twelve months since last sexual contact with another man.
Informationabout FDA HIV product approvals, safety warnings, medical product labeling changes, notices of upcoming public meetings, and notices about proposed regulatory guidances.
The major change being effected is that men who have sex with men will
be deferred from donating blood for twelve months since last sexual contact
with another man, instead of being indefinitely deferred.
As we make this change, we affirm our commitment to further progressing
blood donor deferral policies as supported by scientific evidence that is
developed, including investigation of shorter deferral interval and individual
risk assessment.
If you have any questions, please contact FDA’s Center for Biologics
Evaluation and Research at ocod@xxxxxxxxxxx.
Richard Klein Office of Health and Constituent Affairs Food and Drug Administration
Kimberly Struble Division of Antiviral Products Food and Drug Administration
Steve Morin Office of Health and Constituent Affairs Food and Drug Administration
This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420
